Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Aer Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Aer Therapeutics's investors include OrbiMed, Canaan Partners, Hatteras Venture Partners.
Aer Therapeutics is headquartered in Raleigh, United States.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Aer Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aer Therapeutics — Funding & Investors." VCBacked, February 5, 2025, https://www.vcbacked.co/company/aer-therapeutics. Accessed August 7, 2026.
VCBacked. (2025). Aer Therapeutics — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/aer-therapeutics
{{cite web |title=Aer Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aer-therapeutics |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated